Search results
Frances Kathleen Oldham Kelsey CM ( née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American [1] pharmacologist and physician. As a reviewer for the U.S. Food and Drug Administration (FDA), she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. [2] .
Frances Oldham Kelsey, recipient of the highest recognition attainable for a U. S. civil servant for her role in saving perhaps thousands from death or life-long incapacitation, had a long an...
Learn about the life and achievements of Dr. Frances Oldham Kelsey, who refused to approve thalidomide in the US and prevented a major tragedy of birth defects. She also shaped and enforced FDA drug regulation laws and received many honors and awards.
Biography. In 1960, during her first month at the Food and Drug Administration, Dr. Frances Oldham Kelsey took a bold stance against inadequate testing and corporate pressure when she refused to approve release of thalidomide in the United States.
Learn about the life and achievements of Frances Kelsey, the first woman to earn a PhD in pharmacology and the FDA official who rejected the dangerous drug thalidomide in 1960. Discover how her actions saved thousands of babies from birth defects and changed drug regulations worldwide.
People also ask
Who is Frances Oldham Kelsey?
Why did Frances Oldham Kelsey refuse thalidomide?
Who is Frances Kelsey?
Who was Frances Oldham?
Aug 7, 2015 · Health & Science. Frances Oldham Kelsey, FDA scientist who kept thalidomide off U.S. market, dies at 101. By Adam Bernstein. and. Patricia Sullivan. August 7, 2015 at 12:53 p.m. EDT. Dr....
Aug 7, 2015 · President John F. Kennedy gave Dr. Frances Oldham Kelsey the nation’s highest federal civilian service award in 1962, saying she had “prevented a major tragedy of birth deformities.” The...
